Breelyn Wilky, MD, details personalized therapy approaches for the treatment of patients with GIST.
Breelyn A. Wilky, MD
Advertisement
Breelyn Wilky, MD, is the director of Sarcoma Medical Oncology, The Cheryl Bennet and McNeilly Family Endowed Chair in Sarcoma Research, director of Sarcoma Medical Oncology, and deputy associate director for Clinical Research at the University of Colorado Cancer Center – Anschutz Medical Campus.
Articles by Breelyn A. Wilky, MD
Breelyn A. Wilky, MD, discusses the rationale for investigating the combination of zalifrelimab, balstilimab, and doxorubicin in patients with advanced/metastatic soft tissue sarcoma, and early results from a phase 2 trial.
Breelyn Wilky, MD, discusses the diagnosis and management of desmoid tumors.
Determining the best course of treatment for sarcomas of the bone and soft tissues is a complex process.
Advertisement
Latest Updated Articles
Dr. Wilky on the Diagnosis and Management of Desmoid TumorsPublished: November 19th 2021 | Updated:
Treating Bone and Soft Tissue SarcomasPublished: October 16th 2015 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
3
Oncology Fellows Presents a New Drug Cheat Sheet for Fellows
4
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
5